GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Guardian Pharmacy Services, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$40.14+0.67 (+1.70%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$15.19 (+60.88%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Guardian Pharmacy Services, Inc. grew revenue 10.3% to $1.46B over the twelve months to Jun 30, 2026. Free cash flow was $86.84M, up 100.8% from a year earlier.
Revenue
$1.46B
+10.3% vs. a year earlier
Operating income
$85.44M
TTM Q2 2026
Free cash flow
$86.84M
+100.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.46B
- Net income
- $65.91M
- Free cash flow
- $86.84M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Revenue
$1.46B+10.3% YoY
Gross profit
$316.58M+21.5% YoY
Operating income
$85.44M
Net income
$65.91M
Free cash flow
–
Reported periodTrailing twelve months